Testosterone therapy for transgender men.

[1]  S. Arver,et al.  Effects on Voice Fundamental Frequency and Satisfaction with Voice in Trans Men during Testosterone Treatment-A Longitudinal Study. , 2016, Journal of voice : official journal of the Voice Foundation.

[2]  M. Irwig.  TRANSGENDER CARE BY ENDOCRINOLOGISTS IN THE UNITED STATES. , 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[3]  S. Davis,et al.  Testosterone in women--the clinical significance. , 2015, The lancet. Diabetes & endocrinology.

[4]  B. Dawn,et al.  Normalization of testosterone level is associated with reduced incidence of myocardial infarction and mortality in men. , 2015, European heart journal.

[5]  T. Travison,et al.  Effects of Testosterone Administration for 3 Years on Subclinical Atherosclerosis Progression in Older Men With Low or Low-Normal Testosterone Levels: A Randomized Clinical Trial. , 2015, JAMA.

[6]  E. Gómez-Gil,et al.  Effect of cross-sex hormone treatment on cardiovascular risk factors in transsexual individuals. Experience in a specialized unit in Catalonia. , 2015, Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion.

[7]  M. Colizzi,et al.  Concomitant psychiatric problems and hormonal treatment induced metabolic syndrome in gender dysphoria individuals: a 2 year follow-up study. , 2015, Journal of psychosomatic research.

[8]  S. Reisner,et al.  Testosterone treatment and MMPI-2 improvement in transgender men: a prospective controlled study. , 2015, Journal of consulting and clinical psychology.

[9]  E. Giltay,et al.  Cross-sex hormone use, functional health and mental well-being among transgender men (Toms) and Transgender Women (Kathoeys) in Thailand , 2015, Culture, health & sexuality.

[10]  J. Kaufman,et al.  Body composition, bone turnover, and bone mass in trans men during testosterone treatment: 1-year follow-up data from a prospective case-controlled study (ENIGI). , 2014, European journal of endocrinology.

[11]  A. Bazzocchi,et al.  Effects of three different testosterone formulations in female-to-male transsexual persons. , 2014, The journal of sexual medicine.

[12]  Juno Obedin-Maliver,et al.  Transgender Men Who Experienced Pregnancy After Female-to-Male Gender Transitioning , 2014, Obstetrics and gynecology.

[13]  M. Murad,et al.  Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline. , 2014, The Journal of clinical endocrinology and metabolism.

[14]  P. Maruff,et al.  Transdermal testosterone improves verbal learning and memory in postmenopausal women not on oestrogen therapy , 2014, Clinical endocrinology.

[15]  J. Kaufman,et al.  Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence. , 2014, The journal of sexual medicine.

[16]  G. T’Sjoen,et al.  Voice in female‐to‐male transsexual persons after long‐term androgen therapy , 2014, The Laryngoscope.

[17]  Esther Gómez-Gil,et al.  Effects of cross-sex hormone treatment on cortical thickness in transsexual individuals. , 2014, The journal of sexual medicine.

[18]  P. Lenihan,et al.  Good Practice Guidelines for the Assessment and Treatment of Adults with Gender Dysphoria , 2014 .

[19]  M. Colizzi,et al.  Transsexual patients’ psychiatric comorbidity and positive effect of cross-sex hormonal treatment on mental health: Results from a longitudinal study , 2014, Psychoneuroendocrinology.

[20]  S. Greenland,et al.  Increased Risk of Non-Fatal Myocardial Infarction Following Testosterone Therapy Prescription in Men , 2014, PloS one.

[21]  S. Monstrey,et al.  Sexual desire in trans persons: associations with sex reassignment treatment. , 2014, The journal of sexual medicine.

[22]  J. Kaufman,et al.  Short- and long-term clinical skin effects of testosterone treatment in trans men. , 2014, The journal of sexual medicine.

[23]  A. Shindel.  Depressive Symptoms and Suicidal Thoughts Among Former Users of Finasteride With Persistent Sexual Side Effects: Irwig MS (George Washington Univ, DC) J Clin Psychiatry 73:1220-1223, 2012 § , 2013 .

[24]  C. Dimitrakakis,et al.  Reduced breast cancer incidence in women treated with subcutaneous testosterone, or testosterone with anastrozole: a prospective, observational study. , 2013, Maturitas.

[25]  P. V. van Diest,et al.  Breast cancer development in transsexual subjects receiving cross-sex hormone treatment. , 2013, The journal of sexual medicine.

[26]  M. Colizzi,et al.  Hormonal treatment reduces psychobiological distress in gender identity disorder, independently of the attachment style. , 2013, The journal of sexual medicine.

[27]  J. Kaufman,et al.  Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case-control study. , 2013, European journal of endocrinology.

[28]  J. Finkelstein,et al.  Gonadal steroids and body composition, strength, and sexual function in men. , 2013, The New England journal of medicine.

[29]  M. Meriggiola,et al.  Effects of long-term high dose testosterone administration on vaginal epithelium structure and estrogen receptor-α and -β expression of young women , 2013, International Journal of Impotence Research.

[30]  M. Meriggiola,et al.  A Prospective Study on Sexual Function and Mood in Female-to-Male Transsexuals During Testosterone Administration and After Sex Reassignment Surgery , 2013, Journal of sex & marital therapy.

[31]  Masami Watanabe,et al.  Dose-response analysis of testosterone replacement therapy in patients with female to male gender identity disorder. , 2013, Endocrine journal.

[32]  M. Irwig.  Depressive symptoms and suicidal thoughts among former users of finasteride with persistent sexual side effects. , 2012, The Journal of clinical psychiatry.

[33]  W. J. Meyer,et al.  Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7 , 2012 .

[34]  J. Kaufman,et al.  Bone mass, bone geometry, and body composition in female-to-male transsexual persons after long-term cross-sex hormonal therapy. , 2012, The Journal of clinical endocrinology and metabolism.

[35]  S. Mueller,et al.  Long-term evaluation of cross-sex hormone treatment in transsexual persons. , 2012, The journal of sexual medicine.

[36]  A. Guillamón,et al.  Hormone-treated transsexuals report less social distress, anxiety and depression , 2012, Psychoneuroendocrinology.

[37]  G. Braunstein,et al.  Efficacy and safety of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women. , 2012, The journal of sexual medicine.

[38]  G. T’Sjoen,et al.  Gender identity disorder in twins: a review of the case report literature. , 2012, The journal of sexual medicine.

[39]  G. Pennings,et al.  Reproductive wish in transsexual men. , 2012, Human reproduction.

[40]  K. Conron,et al.  Transgender health in Massachusetts: results from a household probability sample of adults. , 2012, American journal of public health.

[41]  M. Irwig,et al.  Persistent sexual side effects of finasteride for male pattern hair loss. , 2011, The journal of sexual medicine.

[42]  E. Giltay,et al.  A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones. , 2011, European journal of endocrinology.

[43]  G. T’Sjoen,et al.  Sexual desire in female-to-male transsexual persons: exploration of the role of testosterone administration. , 2011, European journal of endocrinology.

[44]  P. Lichtenstein,et al.  Long-Term Follow-Up of Transsexual Persons Undergoing Sex Reassignment Surgery: Cohort Study in Sweden , 2011, PloS one.

[45]  M. Beckmann,et al.  Effects of intramuscular testosterone undecanoate on body composition and bone mineral density in female-to-male transsexuals. , 2010, The journal of sexual medicine.

[46]  A. Jette,et al.  Adverse events associated with testosterone administration. , 2010, The New England journal of medicine.

[47]  Amy T. Wang,et al.  Clinical review 1: Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. , 2010, The Journal of clinical endocrinology and metabolism.

[48]  V. Montori,et al.  Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. , 2010, The Journal of clinical endocrinology and metabolism.

[49]  R. Fanchin,et al.  Histology of genital tract and breast tissue after long-term testosterone administration in a female-to-male transsexual population. , 2010, Reproductive biomedicine online.

[50]  U. Kaufmann,et al.  Incidence of thrombophilia and venous thrombosis in transsexuals under cross-sex hormone therapy. , 2010, Fertility and sterility.

[51]  V. Montori,et al.  Effect of sex steroid use on cardiovascular risk in transsexual individuals: a systematic review and meta‐analyses , 2010, Clinical endocrinology.

[52]  A. Perrone,et al.  Effect of long-term testosterone administration on the endometrium of female-to-male (FtM) transsexuals. , 2009, The journal of sexual medicine.

[53]  H. Ujike,et al.  Association study of gender identity disorder and sex hormone-related genes , 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[54]  V. Montori,et al.  Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. , 2009, The Journal of clinical endocrinology and metabolism.

[55]  Eric Vilain,et al.  Androgen Receptor Repeat Length Polymorphism Associated with Male-to-Female Transsexualism , 2009, Biological Psychiatry.

[56]  G. Braunstein,et al.  Testosterone for low libido in postmenopausal women not taking estrogen. , 2008, The New England journal of medicine.

[57]  L. Gooren,et al.  Long-acting intramuscular testosterone undecanoate for treatment of female-to-male transgender individuals. , 2007, The journal of sexual medicine.

[58]  G. Martorana,et al.  Testosterone decreases adiponectin levels in female to male transsexuals. , 2006, Asian journal of andrology.

[59]  A. Scorilas,et al.  Effects of Long-term Androgen Administration on Breast Tissue of Female-to-Male Transsexuals , 2006, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[60]  Staffan Nilsson,et al.  Sex steroid-related genes and male-to-female transsexualism , 2005, Psychoneuroendocrinology.

[61]  V. Mootha,et al.  Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men. , 2005, Diabetes care.

[62]  A. Aleman,et al.  A single administration of testosterone improves visuospatial ability in young women , 2004, Psychoneuroendocrinology.

[63]  J. Rosing,et al.  Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people. , 2003, The Journal of clinical endocrinology and metabolism.

[64]  E. Giltay,et al.  Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects , 2003, Clinical endocrinology.

[65]  E. Giltay,et al.  Effects of sex steroid deprivation/administration on hair growth and skin sebum production in transsexual males and females. , 2000, The Journal of clinical endocrinology and metabolism.

[66]  E. Barrett-Connor,et al.  A two-year, double-blind comparison of estrogen-androgen and conjugated estrogens in surgically menopausal women. Effects on bone mineral density, symptoms and lipid profiles. , 1999, The Journal of reproductive medicine.

[67]  S. Arver,et al.  Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men. , 1999, The Journal of clinical endocrinology and metabolism.

[68]  C. Ludlam,et al.  The effects of low‐dose testosterone treatment on lipid metabolism, clotting factors and ultrasonographic ovarian morphology in women , 1998, Clinical endocrinology.

[69]  P. V. van Kesteren,et al.  Long‐term follow‐up of bone mineral density and bone metabolism in transsexuals treated with cross‐sex hormones , 1998, Clinical endocrinology.

[70]  Paul van Kesteren,et al.  An epidemiological and demographic study of transsexuals in the Netherlands , 1996, Archives of sexual behavior.

[71]  Dick F. Swaab,et al.  A sex difference in the human brain and its relation to transsexuality , 1995, Nature.

[72]  K. Segal,et al.  Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome , 1989, Diabetes.

[73]  J. Finkelstein,et al.  Physical and hormonal evaluation of transsexual patients: A longitudinal study , 1986, Archives of sexual behavior.